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Malaria and Pregnancy: Placental Cytokine Expression and Its
Relationship to Intrauterine Growth Retardation
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Paul J. Bock,1 Thomas Nyirenda,3
and Steven R. Meshnick1
Departments of 1Epidemiology and 2Pathology, University
of Michigan, Ann Arbor; 3Ministry of Health, Mangochi, Malawi
Malaria infections during pregnancy can lead to the delivery of low–birth-weight infants.
In this study, cytokine mRNA was measured in placentas from 23 malaria-infected and 21
uninfected primigravid women who had delivered in Mangochi, Malawi, a region with a high
rate of transmission of falciparum malaria. Significantly increased expression of interleukin
(IL)–1b, IL-8, and tumor necrosis factor (TNF)–a and decreased expression of IL-6 and
transforming growth factor–b1 were found in malaria-infected compared with uninfected
placentas. TNF-a and IL-8 were produced by maternally derived hemozoin-laden placental
macrophages. Increased TNF-a expression was associated with increased placental hemozoin
concentrations. Increased TNF-a or IL-8 expression in the placenta was associated with in-
trauterine growth retardation but not with preterm delivery. The results suggest that malaria
infections induce a potentially harmful proinflammatory response in the placenta.
Malaria can be quite detrimental to pregnant women. In
areas with a high rate of malaria transmission, primigravid
women are at the greatest risk, whereas in areas with a low
rate of malaria transmission, all pregnant women are at risk.
Maternal malaria has been associated with delivery of
low–birth-weight (LBW) infants because of either preterm de-
livery (PTD) or intrauterine growth retardation (IUGR) [1–3].
LBW infants have elevated risks of dying during the post-
neonatal period [4, 5].
Malaria-associated LBW may have different causes in dif-
ferent epidemiologic settings. In areas with a high rate of ma-
laria transmission, infections early in pregnancy are associated
with IUGR whereas infections later in pregnancy are associated
with PTD [6]. However, the underlying mechanisms responsible
for malaria pathogenesis during pregnancy are not well
understood.
In this study, we measured cytokine mRNA in placental tis-
sue from primigravid women, with and without malaria, living
Received 29 March 1999; revised 30 July 1999; electronically published
12 November 1999.
The study protocol was approved by the Malawi Health Sciences Research
Committee and the University of Michigan Health Sciences Internal Review
Board. Informed consent was obtained from all participants in the study.
Grant support: Conservation, Food, and Health Foundation; Interna-
tional Rotary Foundation; and the National Institutes of Health (D43
TW00908-01).
a Present affiliation: Department of Medicine, Case-Western Reserve Uni-
versity Medical School, Cleveland, Ohio.
Reprints or correspondence: Dr. Steven R. Meshnick, Dept. of Epide-
miology, University of Michigan School of Public Health, 109 Observatory
St., Ann Arbor, MI 48109-2029 (meshnick@umich.edu).
The Journal of Infectious Diseases 1999;180:1987–93
q 1999 by the Infectious Diseases Society of America. All rights reserved.
0022-1899/1999/18006-0029$02.00
in an area of Malawi with a very high transmission rate for
falciparum malaria. We measured several cytokines suspected
of being involved with the pathogenesis of either malaria or
poor birth outcome.
Materials and Methods
Study population. Data were collected at Mangochi District
Hospital in Mangochi District, an area with a high rate of malaria
transmission. Recruitment of subjects and the methods of evalu-
ation are described elsewhere [7]. Placental hemozoin concentra-
tions had been measured in a previous study by using a sensitive
fluorometric assay that could detect as little as 20 ng of hemozoin
heme per milligram of placental protein [8]. Gestational age was
estimated by using the Dubowitz score [9]. Infants delivered before
37 weeks were considered to have had PTDs. Percentile weight for
gestational age was assessed by using a standard population and
controlling for sex of the infant and gravid category of the mother
[10, 11]. The IUGR category consisted of infants in the lowest
tenth percentile of weight for gestational age.
Parasitemia of umbilical cord blood is strongly associated with
poor birth outcome [6, 7]. All available placental biopsy specimens
from women with cord blood parasitemias were used ( ). Forn = 23
the control group, we chose placentas from women who showed
no signs of malaria infection during pregnancy ( ). Althoughn = 21
women in the latter group were probably exposed to malaria, they
never had detectable antenatal or delivery parasitemias, nor did
they have fluorometrically detectable hemozoin in the placenta.
Table 1 provides a summary of characteristics of the infected and
uninfected groups.
Placental sample collection and isolation of total RNA. Whole
placentas were refrigerated until assessment. Within 16 h of deliv-
ery, placental samples were collected from an area ∼1 inch from
the point of insertion of the cord, as described by Bulmer et al.
[12]. These samples were rinsed in saline, placed in a cryovial, and
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Table 1. Summary of study population characteristics.
Characteristic Infected Uninfected P
No. of subjects 23 21
Gestational age (w) 37.2 5 2.0 38.7 5 1.4 .01
Birth weight (g) 2671 5 460 3030 5 417 .01
Term deliveries 10 (43.5) 17 (80.9) .012
PTD only 7 (30.4) 1 (4.8) .007
IUGR only 4 (17.4) 3 (14.3) .28
PTD and IUGR 2 (8.7) 0 .27
NOTE. Data are no. (%) of subjects or . IUGR, intrauterinemean 5 SD
growth retardation; PTD, preterm delivery.
frozen in liquid nitrogen. Samples were transported in a dry shipper
from Malawi to the University of Michigan, where further analysis
was conducted. Total RNA was extracted from the placental sam-
ples by using the method of Chomczynski and Sacchi [13] with the
following modifications. Between 100 and 800 mg of tissue was
homogenized in 1 mL of solution D (4 M guanidine thiocyanate;
25 mM sodium citrate, pH 7.0; 0.5% [wt/vol] sarcosyl) with 0.1 M
b-mercaptoethanol per 100 mg of tissue by using loose-fitting
Dounce tissue grinders (0.0035–0.0055 inch of clearance; Wheaton
Scientific, Millville, NJ). The RNA samples were extracted with
phenol-chloroform (GibcoBRL, Grand Island, NY) and then pre-
cipitated by isopropanol, resuspended, and precipitated by ethanol.
The isolated RNA was washed with 80% ethanol and dissolved in
high-performance liquid chromotography–grade, ribonuclease
(RNase)–free water (Fisher Scientific, Pittsburgh). RNA was stored
in aliquots at 2807C until its use.
Ribonuclease protection assay (RPA). RPAs were performed
as described elsewhere [14]. Two cytokine-specific riboprobe tem-
plate sets, HL-14 and HL-23, were assembled from EcoRI-lin-
earized and -purified subclones [15]. The HL-14 template set syn-
thesized riboprobes specific for human interleukin (IL)–6, IL-10,
IL-1a, tumor necrosis factor (TNF)–b, granulocyte-macrophage
colony–stimulating factor (GM-CSF), transforming growth factor
(TGF)–b1, IL-1b, TNF-a, and rpL32. The HL-23 template set
synthesized riboprobes specific for human IL-12p40, IL-4, IL-5,
interferon (IFN)–g, IL-2, IL-13, IL-12p35, and rpL32. In this study,
IL-8 replaced IL-13 in the HL-23 template set. The RPA riboprobe
subclones were generated as described elsewhere [15] with the ad-
dition of IL-8 (nucleotides 2467–2598; GenBank accession no.
M28130). All riboprobe syntheses were driven by T7 bacteriophage
RNA polymerase (Promega, Madison, WI) with [a-32P] UTP (3000
Ci/mmol) (Amersham, Arlington Heights, IL) as the labeling nu-
cleotide in an in vitro transcription reaction. The subsequent steps
of probe purification, total placental RNA (15 mg)–probe hybrid-
ization, RNase treatment, purification of protected RNA duplexes,
and resolution of protected probes by standard 5% acrylamide/8-
M urea sequencing gels were performed exactly as described by
Hobbs et al. [14]. Probe bands were visualized by autoradiography
(XAR film; Kodak, Rochester, NY) and were quantified with
Storm PhosphorImager and ImageQuant software (Molecular Dy-
namics, Sunnyvale, CA). For the latter task, volume measurements
with rectangular objects were used to generate PhosphorImager
(PI) counts. PI counts were normalized to account for varying
numbers of incorporated [a-32P] UTPs for each probe, as well as
for lane-to-lane and assay-to-assay variability, and each PI count
is presented as a fraction of the internal housekeeping signal
(rpL32) in each lane.
Reverse transcription–polymerase chain reaction (RT-PCR).
Total RNA from each placental sample was used as the template
for RT-PCR with the GeneAmp RNA PCR kit (PE Biosystems,
Foster City, CA) according to the manufacturer’s instructions. For
amplification of human immunodeficiency virus (HIV) sequences,
gag-specific primers SK38 and SK39 [16] were used. IL-1a was
amplified as a positive control by using primers DM151 and
DM152 supplied in the GeneAmp kit. The PCR mix was initially
heated at 957C for 3 min, with the PCR primers added at 30 s.
PCR was then done for 43 cycles of 30 s at 947C and 1 min at
607C, followed by a final extension of 7 min at 727C in a PTC-100
thermocycler (MJ Research, Watertown, MA).
For a positive control, HIV cDNA was provided by Dr. Stephen
King at the University of Michigan in Ann Arbor. HIV cDNA
was further diluted into placental cDNA (derived from the RT of
1 mg total RNA) to a concentration of 100 copies of HIV per
reaction. The amplified PCR products were analyzed by 2% agarose
gel electrophoresis with ethidium bromide (5 mg/mL) staining. The
signal intensities of the bands were scored as either greater or less
than 100 copies of HIV per microgram of total RNA.
Antibodies and immunohistochemistry (IHC). Mouse mono-
clonal antibodies were purchased from Pharmingen (San Diego).
Optimal concentrations were 20 mg/mL for anti-human TNF-a
(clone mAb11) and 10 mg/mL for anti-human IL-8 (clone G265-
8). Purified mouse IgG1, k-isotype standard (clone MOPC-21),
served as the negative control. Acetone-fixed frozen sections were
stored at 2807C until stained. Standard indirect immunostaining
was performed with solutions containing 0.1% saponin. PBS-re-
hydrated sections were serially pretreated with 1% H2O2, avidin-
biotin, and a 1 : 50 dilution of normal goat serum (BioGenex, San
Ramon, CA). Then optimal dilutions of cytokine-specific and con-
trol antibodies were applied for 1–2 h at room temperature. After
washing, 10 mg/mL biotin-conjugated goat anti-mouse IgG was
applied for 30 min. The slides were washed in saponin-free PBS,
overlaid with ABC reagent (Vector Laboratories, Burlingame, CA)
for 15 min, washed again, and then incubated with the substrate
(3-amino-9-ethyl carbazole [AEC]) for 2–5 min. The substrate was
rinsed away with water, and Mayer’s hematoxylin was used as a
counterstain for viewing.
Statistical analyses. Methods used included F tests for 2-sam-
ple variances, 2-tailed t tests for significant differences in means,
and linear regression done with Microsoft Excel 97 (Redmond,
WA). A 1-tailed Fisher’s exact test was done with Epi Info 6.04b
(Centers for Disease Control and Prevention, Atlanta, GA) to as-
sess relationships between pairs of variables. Bonferroni’s adjust-
ment was used as a more conservative measure of significance
( ) for multiple comparisons [17].a = 5%
Results
Placental cytokine expression pattern associated with malaria
infection. We measured RNA levels for a number of cytokines
in malaria-infected and -uninfected placentas. None of the pla-
centas contained RNA for IFN-g, IL-2, IL-4, IL-5, IL-12, or
GM-CSF (data not shown). RNA for IL-1a, TNF-b, and IL-
10 was detected, but there were no significant differences be-
tween infected and uninfected placentas (table 2). In contrast,
we found significant ( ) differences in mRNA levels be-P ! .05
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IL-1a 0.09750.092 0.09050.086 1.08 .80
IL-1b 1.0151.05 0.32850.41 3.08 .007
IL-6 0.00750.006 0.01150.008 0.60 .04
IL-8 0.76350.768 0.35850.241 2.13 .02
IL-10 0.01750.032 0.01450.010 1.21 .76
TGF-b1 2.59551.106 5.28854.143 0.49 .005b
TNF-a 0.47550.511 0.12350.083 3.86 .004b
TNF-b 0.03250.021 0.03750.022 0.86 .50
NOTE. IL, interleukin; TGF, transforming growth factor; TNF, tumor
necrosis factor.
a Ratio of volume of cytokine signal to that of rpL32, a housekeeping gene,
in same lane on the gel.
b Significant ( ) after Bonferroni’s adjustment for multiplea = 5%
comparisons.
tween infected and uninfected placentas for IL-6, TGF-b1, IL-
1b, IL-8, and TNF-a (table 2). In the infected placentas, IL-6
and TGF-b1 transcripts decreased by 40% and 51%, respec-
tively, whereas IL-1b, IL-8, and TNF-a increased 3-fold, 2-
fold, and almost 4-fold, respectively. Using Bonferroni’s ad-
justment for multiple comparisons, the differences in TGF-b
and TNF-a expression remained significant, and IL-1b was
borderline significant.
Degradation not the cause of differences in cytokine RNA
levels. Varying periods of time elapsed between delivery and
processing of the placenta (15 min to 16 h). Regression analyses
were performed to determine whether the elapsed time affected
cytokine mRNA levels. The average times before freezing were
h for infected samples and h for un-7.07 5 4.01 4.96 5 4.96
infected samples. No significant differences were found (data
not shown).
HIV screening of placental RNA by RT-PCR. In general,
trophoblastic cells of HIV-positive placentas express signifi-
cantly higher levels of IL-1b, IL-6, and TNF-a compared with
those of uninfected placentas [18]. Therefore, RT-PCR was per-
formed on placental RNA to screen samples for HIV. The low-
est level of detection by this method was 100 copies of HIV
present in 1 mg of total placental RNA. None of the 44 samples
evaluated in this study had HIV levels 1100 copies in 1 mg of
total RNA. IL-1a expression was used as a positive control for
RT-PCR and was successfully detected in all samples (data not
shown).
Placental hemozoin concentration associated with TNF-a ex-
pression. Placental hemozoin is a good marker of past or
current malaria infection [12]. Hemozoin concentrations from
the placentas used in this study had been assayed in a previous
study by using a fluorometric assay [8]. We performed regres-
sion analysis on the infected samples to determine whether he-
mozoin concentrations were correlated with placental cytokine
expression. Of all of the cytokines listed in Table 2, only TNF-
a showed a positive association with hemozoin in the placenta
( , ), which was significant after Bonferroni’s2R = .47 P ! .0003
adjustment for multiple comparisons).
Detection of IL-8 and TNF-a in placental tissue sections by
IHC. Using IHC, we verified that IL-8 and TNF-a tran-
scripts were being translated, and we identified which placental
cell types were involved in their expression. In uninfected pla-
cental samples, anti–IL-8 monoclonal antibodies stained the
fetal vascular endothelial cells within the chorionic villi (figure
1A). Malaria-infected placental sections incubated with
anti–IL-8 monoclonal antibodies also showed staining of the
fetal vascular endothelial cells within the chorionic villi (figure
1B). In addition, some hemozoin-laden placental macrophages
stained positively for IL-8. Placental sections from malaria-
infected samples stained with mouse IgG control antibodies
were negative (figure 1C). When malaria-infected placental
samples were incubated with monoclonal antibodies against
TNF-a, we found staining localized to some hemozoin-laden
macrophages (figure 2A). Staining was absent in most hemo-
zoin-laden macrophages, in macrophages without hemozoin,
and in other cell types. Malaria-infected placental samples in-
cubated with mouse IgG control antibodies were negative (fig-
ure 2B). Uninfected placental samples stained with anti–TNF-
a were negative (data not shown). Slides stained with
anti–TNF-a antibodies showed a punctate nonspecific staining
pattern throughout that was similar to the pattern seen on slides
stained with the IgG control antibody.
Elevated placental expression of either TNF-a or IL-8 asso-
ciated with IUGR. In the larger study population, 36.6% of
deliveries were associated with poor birth outcomes [7]. Ac-
cordingly, we dichotomized TNF-a and IL-8 expression levels
in infected placenta, so that women whose levels were in the
top 35% were classified as high expressers and the others were
classified as low expressers. We counted birth outcomes as nor-
mal, IUGR, or PTD. Those that were both IUGR and PTD
were included in both analyses. Fisher’s exact test showed that
elevated levels of TNF-a or IL-8 expression were not associated
with PTD ( and , respectively). In general, ele-P = .63 P = .37
vated TNF-a or IL-8 had a weak association, or no association,
with poor birth outcomes (combined PTD and IUGR; P =
and , respectively). However, IUGR was significantly.63 P = .04
associated with elevations in either TNF-a or IL-8 levels
( for both).P = .0086
Discussion
Placentas with evidence of past or present malaria infections
produce a different blend of cytokines than placentas without
such evidence. Infected placentas had 2–4 times the amount of
IL-1b, IL-8, and TNF-a mRNA, and about half as much IL-
6 and TGF-b1 RNA as uninfected placentas. Among the in-
fected placentas, higher hemozoin content was associated with
a greater amount of TNF-a mRNA. IHC showed that he-
mozoin-laden macrophages produce both TNF-a and IL-8. In-
creased expression of either TNF-a or IL-8 appears to be as-
sociated with IUGR. The association seen here between either
TNF-a or IL-8 and IUGR is provisional because it was found
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Figure 1. Placental tissue sections stained with mouse monoclonal
anti–interleukin (IL)-8 antibodies from uninfected sample (A) and ma-
laria-infected sample (B); IgG control antibody staining of malaria-
infected placental sample (C) with streptavidin-biotin immunostain and
hematoxylin counterstain. Long arrows indicate IL-8 staining of fetal
endothelial cells in chorionic villi in both uninfected and infected pla-
cental tissue. Bold arrows indicate hemozoin-laden macrophages that
were positive for IL-8 staining in infected tissue or were not stained in
IgG control sample. Insets provide magnified views of hemozoin-laden
macrophages and staining patterns. Original magnification, 31000 (oil
immersion).
in a relatively small sample. However, the P values were quite
robust, and the data are consistent with those of previous stud-
ies on both malarial [19] and nonmalarial [20] causes of LBW.
Our observations of increased proinflammatory cytokines
(TNF-a and IL-1b) and decreased anti-inflammatory cytokines
(IL-6 and TGF-b) are consistent with the results of many other
studies, reviewed by Clark et al. [21], that show that severe
malaria infections tend to be associated with increased proin-
flammatory cytokines in the peripheral circulation. The only
exception is an increase in IL-6, which has been associated with
increased severity of malaria [22], even though IL-6 is anti-
inflammatory [23]. Thus, the role of IL-6 in pathogenesis needs
further clarification.
Previous studies have also shown proinflammatory responses
in placentas from malaria-infected women [19, 24]. In a study
by Fried et al. [19], placentas from infected primigravid women
had more TNF-a, about the same amount of IL-10, and less
IL-6 compared with placentas from uninfected women. Pla-
cental TNF-a was associated with poor birth outcome. These
results are almost identical to those reported here.
The major difference between our study and that of Fried
et al. [19] is that we measured cytokine mRNA, whereas the
latter group measured cytokine protein. For the cytokines IFN-
g, IL-2, and IL-4, Fried et al. detected the protein in placentas,
whereas we did not detect the corresponding RNA. Also, Fried
et al. detected slightly more placental TGF-b in infected women
than in uninfected women, whereas we detected significantly
less TGF-b RNA in infected women. Two possible explanations
for differences between measurements of placental cytokine
protein and RNA are as follows. First, some cytokine protein
present in the placenta might have been synthesized outside of
the placenta. Second, it is possible that the mRNA for some
cytokines is especially labile and might deteriorate during
storage.
Unlike the other cytokines measured in this study, IL-8 is a
chemokine. Our finding of increased IL-8 in malaria-infected
placentas is consistent with the results of a previous study that
showed that malaria infections are associated with elevated lev-
els of IL-8 in the peripheral circulation [25].
Our study is the first to determine which placental cells are
responsible for malaria-associated cytokine production. Both
TNF-a and IL-8 were made by only some hemozoin-laden
placental macrophages. The presence of hemozoin in macro-
phages suggests that the cell had previously phagocytosed a
malaria-infected erythrocyte or parasite-derived debris. The in-
duction of TNF-a production in macrophages by the
phagocytosis of parasites is consistent with the in vitro obser-
vations of Xiao et al. [26]. It is predictable that TNF-a would
be expressed in only a minority of these macrophages, because
TNF-a can be produced for only a limited time after the action
of a phagocytic stimulus. Also, the production of IL-8 by fetal
endothelial cells is consistent with the results of previous studies
in which other cytokines were found to be produced by this
cell type in uninfected placentas [27].
Selection bias may have affected our results. In particular,
because HIV-infected pregnant women are more likely to have
parasitemias than women who are not HIV infected [28, 29],
the malaria-infected group could have had a higher prevalence
Figure 2. Malaria-infected placental tissue section stained with mouse monoclonal anti–tumor necrosis factor (TNF)–a antibodies (A) and
IgG control (B), and streptavidin-biotin immunostain with hematoxylin counterstain. Long arrows indicate TNF-a staining in hemozoin-laden
macrophages. Bold arrows indicate hemozoin pigment in macrophages. Insets provide magnified views of hemozoin-laden macrophages and
staining pattern. Original magnification, 31000 (oil immersion).
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of HIV infection. Even though no HIV virus was detected in
any placenta used in this study, some of the mothers may have
been infected with HIV. Given that both placental monocytes
and trophoblasts from HIV-infected women produce increased
amounts of proinflammatory cytokines [18], HIV could have
mediated the effect measured in this study. However, HIV status
does not seem to affect the prevalence of cord blood parasitemia
[29]. Also, TNF-a production appears to depend on the pres-
ence of PCR-detectable virus [18], and no PCR-detectable vi-
ruses were found in the placentas we studied. Thus, this con-
founding effect is not likely. In addition, the fact that TNF-a
and IL-8 were visualized in macrophages containing parasite
remnants (hemozoin) suggests that malaria directly induces
these cytokines.
Malaria-induced alterations in cytokine secretion might me-
diate the effects of malaria on a first pregnancy. TNF-a and
IL-1 play a role in normal fetal development and parturition
[30, 31]. IL-1b and IL-8 appear to be responsible for normal
cervical ripening [32]. Increased placental TNF-a, IL-1, and
IL-8 have been associated with PTD that is due to other causes
[32–39]. TNF-a and IL-1b may have this effect by increasing
prostaglandin synthesis and efficacy [40–42]. Increased placen-
tal TNF-a may cause IUGR [20] by preventing nutrient uptake
by the fetus [43].
The importance of cytokines in mediating the effects of ma-
laria on pregnancy is consistent with the observation that Plas-
modium vivax infections also adversely affect birth outcome
[44]. P. vivax infections are associated with greater increases in
TNF-a than P. falciparum infections [45].
In summary, malaria infections in primigravid women appear
to cause significant alterations in the pattern of placental cy-
tokine synthesis. These alterations might be responsible for
some of the LBW observed in the offspring.
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